Table 4.
Association between LAAT and clinical variables in the second study.
| Variables | HR | 95% CI | p value |
|---|---|---|---|
| Univariate analysis | |||
| Age ⩾65 years | 2.854 | 1.436–5.672 | 0.003 |
| gender | 0.924 | 0.474–1.798 | 0.815 |
| SBP | 1.017 | 0.999–1.036 | 0.063 |
| DBP | 1.018 | 0.991–1.046 | 0.184 |
| BMI | 1.066 | 0.977–1.163 | 0.152 |
| AF type | 2.523 | 1.491–4.269 | 0.001 |
| OMI | 0.699 | 0.095–5.124 | 0.725 |
| Vascular disease | 0.046 | 0.000–38.803 | 0.370 |
| CHD | 1.222 | 0.593–2.515 | 0.587 |
| Hyperlipidemia | 0.878 | 0.444–1.735 | 0.708 |
| Diabetes mellitus | 1.761 | 0.901–3.443 | 0.098 |
| Congestive heart failure | 1.930 | 0.460–8.099 | 0.369 |
| Prior stroke or TIA | 3.781 | 1.647–8.683 | 0.002 |
| Smoking history | 0.907 | 0.444–1.853 | 0.790 |
| Drinking history | 1.359 | 0.592–3.119 | 0.469 |
| ACEI/ARB | 0.487 | 0.247–0.958 | 0.037 |
| Antiplatelet drugs | 0.545 | 0.279–1.061 | 0.074 |
| Statins | 0.919 | 0.471–1.791 | 0.803 |
| Multivariate analysis | |||
| Age ⩾65 years | 2.266 | 1.066–4.817 | 0.033 |
| SBP | 1.023 | 1.003–1.044 | 0.026 |
| AF type | 1.727 | 0.949–3.143 | 0.074 |
| Diabetes mellitus | 2.250 | 1.076–4.702 | 0.031 |
| Prior stroke or TIA | 2.630 | 0.952–7.269 | 0.062 |
| ACEI/ARB | 0.368 | 0.170–0.797 | 0.011 |
| Antiplatelet drugs | 0.818 | 0.391–1.710 | 0.594 |
LAAT: left atrial appendage thrombus; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; AF: atrial fibrillation; OMI: old myocardial infarction; CHD: coronary heart disease; TIA: transient ischemic attack; ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; HR: hazard ratio; CI: confidence interval.